Skip to main content
Arthritis Research & Therapy logoLink to Arthritis Research & Therapy
. 2022 Oct 25;24:238. doi: 10.1186/s13075-022-02929-0

Correction: The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study

Boyoon Choi 1,2, Hyun Jin Park 1, Yun-Kyoung Song 1,3, Yoon-Jeong Oh 4, In-Wha Kim 1, Jung Mi Oh 1,
PMCID: PMC9594875  PMID: 36284316

Correction: Arthritis Res Ther 24, 191 (2022)

https://doi.org/10.1186/s13075-022-02868-w

Following publication of the original article [1], the authors reported that author Boyoon Choi’s affiliation “College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea” was inadvertently removed.

The affiliation has been updated above and the original article [1] has been corrected.

Reference

  • 1.Choi B, Park HJ, Song YK, et al. The risk of newly diagnosed cancer in patients with rheumatoid arthritis by TNF inhibitor use: a nationwide cohort study. Arthritis Res Ther. 2022;24:191. doi: 10.1186/s13075-022-02868-w. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Arthritis Research & Therapy are provided here courtesy of BMC

RESOURCES